AstraZeneca PLC
LSE:AZN
AstraZeneca PLC
LSE:AZN
Price:
11 268 GBX
0.16%
Market Closed
Updated:
Apr 23, 2024
AstraZeneca PLC
Free Cash Flow
Last
Value
3-Years CAGR
5-Years CAGR
|
AstraZeneca PLC
Free Cash Flow Peer Comparison
Comparables:
GSK
VRNA
INDV
HIK
DPH
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AstraZeneca PLC
LSE:AZN
|
Free Cash Flow
$6.6B
|
CAGR 3-Years
44%
|
CAGR 5-Years
39%
|
CAGR 10-Years
2%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Free Cash Flow
£4.4B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-2%
|
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Free Cash Flow
$-50.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Indivior PLC
LSE:INDV
|
Free Cash Flow
$-368m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Free Cash Flow
$404m
|
CAGR 3-Years
19%
|
CAGR 5-Years
7%
|
CAGR 10-Years
4%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Free Cash Flow
£33.3m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
2%
|
See Also
What is AstraZeneca PLC's Free Cash Flow?
Free Cash Flow
6.6B
USD
6.6B
USD
Based on the financial report for Dec 31, 2023, AstraZeneca PLC's Free Cash Flow amounts to 6.6B USD.
What is AstraZeneca PLC's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
2%
2%
Over the last year, the Free Cash Flow growth was -9%. The average annual Free Cash Flow growth rates for AstraZeneca PLC have been 44% over the past three years , 39% over the past five years , and 2% over the past ten years .
You don't have any saved screeners yet
